Annals of Oncology Advance Access originally published online on August 12, 2005
Annals of Oncology 2006 17(1):173-174; doi:10.1093/annonc/mdj004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
letter to the editor |
Reply to "Troponins in prediction of cardiotoxic effects", by D. Cardinale et al.
| The first 10% of the full text of this article appears below. |
We have read the interpretation of our study [1
] by Cardinale et al. [2
]. We would like to thank the authors for their interest. The increase in serum levels of cardiac troponin I and T (cTnI and cTnT) occur due to myocardial damage and are generally used to detect acute myocardial infarction. Since cardiotoxicity can be
1 Hacettepe University Institute of Oncology, Department of Medical Oncology, Ankara; 2 Hacettepe University Faculty of Medicine, Department of Cardiology, Ankara, Turkey
* E-mail: skilickap@yahoo.com